TARGET
saveCTLA-4
Cytotoxic T-lymphocyte-associated protein 4; immune checkpoint.
also known as: cd152, anti-ctla-4
drugs
0
catalysts
0
news
14
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- AstraZeneca scraps Phase 3 trial of new bispecific in lung cancerbiopharma dive · 4d ago
- AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytrudafiercebiotech · 4d ago
- As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca mergerbiospace · 17d ago
- After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyfiercebiotech · 18d ago
- Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad ideafiercebiotech
comments(0)
5-min edit window · permanent after that